IPO Details
Bidding Dates
30 Mar '23 - 04 Apr '23
Minimum Investment
₹135,000 / 1 Lots ( 1000 Shares )
Price Range
₹135
Maximum Investment
₹135,000 / 1 Lots ( 1000 Shares )
Retail Discount
To be announced
Issue Size
₹25.31 crore
Investor category and sub category
Qualified Institutional Buyers | Non-Institutional Investors | Retail Individual Investors |IPO Dates
Important dates with respect to IPO allotment and listing
IPO Opening Date
Mar 30, 2023
IPO Closing Date
Apr 4, 2023
Basis of Allotment
Apr 10, 2023
Initiation of Refunds
Apr 11, 2023
Credit of Shares to Demat Account
Apr 12, 2023
IPO Listing Date
Apr 16, 2023
Infinium Pharmachem IPO Subscription Details
| Date | NII | Retail | Total |
|---|---|---|---|
Day 1Mar 30, 2023 |
0.06 | 0.10 | 0.08 |
Day 2Apr 2, 2023 |
0.31 | 0.57 | 0.44 |
Day 3Apr 4, 2023 |
1.80 | 1.86 | 1.84 |
IPO Subscription Status Live
| Investor Category | Subscription (Times) |
|---|---|
| Qualified Institutions Buyers | [.] |
| Non-Institutional Buyers | 1.80 |
| Retail Investors | 1.86 |
| Employees | [.] |
| Other | [.] |
| Total | 1.84 |
About Company
Infinium Pharmachem manufactures and markets Iodine Derivatives, APIs, and Iodination reaction-based bulk drugs. The company is based in Gujarat and has been operating since 2003. It will undertake contract research and manufacturing services (CRAMS) to offer its clients customised and fully confidential solutions. The company has built skills to expertly cater to industries such as pharmaceutical & biotech, speciality & performance chemicals, agrochemicals, human & animal health, cosmetics, sanitation, electrical, electronics etc.
The company caters to 250 plus clients globally across 15+ countries. Its product suite contains 200+ Iodine Derivatives and 7+ APIs.
Infinium Pharmachem IPO worth Rs.25.31 crore from 1,875,000 equity shares will open for subscription on March 31, 2023. The fixed issue IPO will be available in the price band of Rs. 135 per share with 1000 shares a lot.
Infinium Pharmachem Ltd. IPO Objective
- The company will spend the net proceed from the IPO for marketing and branding expenses
- To meet incremental working capital requirement
- Repay some of the existing market borrowings
- To meet public issue expenses
Should you invest in Infinium Pharmachem Ltd.?
These are the top reasons to consider investing in Infinium Pharmachem Ltd.
- Iodine is a critical element in human nutrition. The increasing rate of iodine deficiency in adults is a global problem and further boosts the market for iodine derivatives.
- The iodine derivative market in India is expected to hit a 6% CAGR.
- The company has a robust product suite of 200+ Iodine Derivatives and 7+ APIs.
- The company possesses strong R&D skills.
- A strong network of quality raw material suppliers helps the company bypass several supply chain bottlenecks.
Infinium Pharmachem Ltd. Noteworthy highlights
- Infinium Pharmachem would gain as the Iodine Derivatives and API markets grow domestically and internationally.
- The global iodine derivative market was valued at $659.5 million and is projected to reach $970.5 million by 2030, growing at 4.38% CAGR from 2023-2030.
- The company belongs to India’s pharmaceutical sector, currently valued at $50 billion.
Infinium Pharmachem Company Financials
| Particulars | Year ending on March 31, 2022 (₹ Lakh) | Year ending on March 31, 2021 (₹ Lakh) | Year ending on March 31, 2020 (₹ Lakh) |
|---|---|---|---|
| Revenue from Operations | 7,403.77 | 5,455.79 | 3,603.84 |
| Profit After Tax (PAT) | 550.34 | 271.94 | 101.81 |
| EBITDA | 1096.60 | 557.60 | 305.82 |
| EPS | 60.07 | 26.80 | 9.19 |
| Period Ended | As on March 31, 2022 (₹ Lakh) | As on March 31, 2021 (₹ Lakh) | As on March 31, 2020 (₹ Lakh) |
| Current Asset | 3,393.30 | 2,231.01 | 1,605.09 |
| Current Liabilities | 2,288.31 | 1,796.98 | 1,060.64 |
Know before investing
Strengths
3-
The company has built long-term healthy relationships with all its clients across sectors.
-
A competitive research facility allows the firm to offer customised solutions to clients and meet their demands timely.
-
The company is aggressively expanding its international and domestic outreach.
Risks
3-
Low market penetration in new markets will keep investors worried.
-
A sudden increase in demand for product baskets has increased the inventory and interest expenses.
-
The company's debt situation can be a reason to worry for future investors.
Login to Angel One App / Website & click on IPO
Select desired IPO & tap on "Apply"
Enter UPI ID, set quantity/price & submit
Accept mandate on the UPI app to complete the process
Login to Angel One App / Website
Choose IPO section on Home Page
Click IPO Orders
Chose the IPO application you want to view the status for
Infinium Pharmachem IPO FAQs
Infinium Pharmachem Ltd. Ltd. IPO worth Rs.25.31 crore will open for subscription on March 31, 2023. The IPO size contains 1,875,000 equity shares with a face value of Rs.10 per share.
The price for the IPO shares is set at Rs. 135 per share.
The basis of the allotment date isApril 11, 2023.
One lot of Infinium Pharmachem Ltd. IPO has 1000 shares.
The IPO will open on March 31, 2023.
Retail investors can apply for a minimum of one lot.
The listing date of Infinium Pharmachem Ltd. Ltd. on NSE SME is April 17, 2023.
You can check the allotment status of your IPO application from the Angel One app.
To check the allotment status, enter the application number, DP ID, and PAN number into the app.
Listing gains cannot be ascertained before the IPO is listed on the exchange. You can get this information on the listing date for Command Polymer Ltd., which is April 17,2023.
The bank initially blocks the amount you bid for an IPO. It will debit the money when the shares are allotted or unblock the amount after the UPI mandate expiry date.
Login to your UPI handle and approve the payment mandate to complete the IPO application process.
You can submit only one application using one PAN card.
The minimum size of the application will be one lot of 1000 shares.
